Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review

被引：7

作者：

Chang, Kaixi ^{[1
]}

Li, Yupei ^{[1
]}

Qin, Zheng ^{[1
]}

Zhang, Zhuyun ^{[1
]}

Wang, Liya ^{[1
]}

Yang, Qinbo ^{[1
]}

Geng, Jiwen ^{[1
]}

Deng, Ningyue ^{[1
]}

Chen, Shanshan ^{[1
]}

Su, Baihai ^{[1
,2
,3
]}

机构：

[1] Sichuan Univ, West China Hosp, Dept Nephrol, Chengdu, Peoples R China

[2] Sichuan Univ, Medx Ctr Mat, Chengdu, Peoples R China

[3] Sichuan Univ, Med Biomat Inst West China Hosp, Chengdu, Peoples R China

来源：

FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷

关键词：

COVID-19; hemoadsorption; cytokine storm; inflammatory mediators; immunomodulatory; blood purification; BLOOD PURIFICATION THERAPIES; RENAL REPLACEMENT THERAPY; CYTOKINE STORM; SINGLE-CENTER; OPEN-LABEL; ORGAN SUPPORT; HEMOPERFUSION; PNEUMONIA; SEPSIS; DYSFUNCTION;

D O I：

10.3389/fimmu.2023.1074465

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

COVID-19 has been affecting the world unprecedentedly and will remain widely prevalent due to its elusive pathophysiological mechanism and the continuous emergence of new variants. Critically ill patients with COVID-19 are commonly associated with cytokine storm, multiple organ dysfunction, and high mortality. To date, growing evidence has shown that extracorporeal hemoadsorption can exert its adjuvant effect to standard of care by regulating immune homeostasis, reducing viremia, and decreasing endotoxin activity in critically ill COVID-19 cases. However, the selection of various hemofilters, timing of initiation and termination of hemoadsorption therapy, anticoagulation management of extracorporeal circuits, identification of target subgroups, and ultimate survival benefit remain controversial. The purpose of this narrative review is to comprehensively summarize the rationale for the use of hemoadsorption in critically ill patients with COVID-19 and to gather the latest clinical evidence in this field.

引用

页数：12

共 122 条

[11] Extracorporeal immune modulation in COVID-19 induced immune dysfunction and secondary infections: the role of oXiris® membrane [J].

Cascarano, Laura ;

Cutuli, Salvatore L. ;

Pintaudi, Gabriele ;

Tanzarella, Eloisa S. ;

Carelli, Simone ;

Anzellotti, Gianmarco ;

Grieco, Domenico L. ;

De Pascale, Gennaro ;

Antonelli, Massimo .

MINERVA ANESTESIOLOGICA, 2021, 87 (03) :384-385

[12] Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients? [J].

Chen, Gang ;

Zhou, Yangzhong ;

Ma, Jie ;

Xia, Peng ;

Qin, Yan ;

Li, Xuemei .

RENAL FAILURE, 2020, 42 (01) :483-488

[13]

Chen L., 2020, J INFECTION, V36, P1228, DOI [10.3969/j.issn.1001, DOI 10.3969/J.ISSN.1001]

[14] Regional citrate and systemic heparin are adequate to maintain filter half-life for COVID-19 patients on continuous renal replacement therapy [J].

Chiao, Cassandra ;

Faust, Hilary ;

Singh, Tripti .

SEMINARS IN DIALYSIS, 2022, 35 (04) :325-329

[15] A Multicenter Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19 [J].

Chitty, Stephen A. ;

Mobbs, Sarah ;

Rifkin, Brian S. ;

Stogner, Steven W. ;

Lewis, Michael S. ;

Betancourt, Jaime ;

Dellavolpe, Jeffrey ;

Abouzahr, Fadi ;

Wilhelm, Andrew M. ;

Szerlip, Harold M. ;

Parikh, Amay ;

Gaeta, Robert M. ;

Rivera, Ian ;

Park, Caroline ;

Levi, Benjamin ;

Anesi, George L. ;

Alcover, Karl C. ;

Arnold, Thomas B. ;

Howard, Jeffrey T. ;

Sharma, Kumar ;

Pratt, Kathleen P. ;

Stewart, Ian J. ;

Chung, Kevin K. .

CRITICAL CARE EXPLORATIONS, 2022, 4 (04) :E0662

[16] Effect of artificial liver blood purification treatment on the survival of critical ill COVID-19 patients [J].

Dai, Xiahong ;

Zhang, Yimin ;

Yu, Liang ;

Jiang, Ying-an ;

Chen, Liang ;

Chen, Ye ;

Li, Ming ;

Gao, Chunming ;

Shang, Jia ;

Xiang, Shulin ;

Li, Yongguo ;

Li, Jianzhou ;

Zhou, Chenliang ;

Zhou, Xiaoyang ;

Chen, Nan ;

Liu, Yuanchun ;

Liu, Jing ;

Zhang, Yuanyuan ;

Chen, Xiaobei ;

Zhu, Danhua ;

Gao, Hainv ;

Tang, Lingling ;

Zhu, Mengfei ;

Li, Lanjuan .

ARTIFICIAL ORGANS, 2021, 45 (07) :762-769

[17] Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19 [J].

Darazam, Ilad Alavi ;

Kazempour, Muhanna ;

Pourhoseingholi, Mohamad Amin ;

Hatami, Firouze ;

Rabiei, Mohammad Mahdi ;

Gharehbagh, Farid Javandoust ;

Amirdosara, Mahdi ;

Hajiesmaeili, Mohammadreza ;

Shabani, Minoosh ;

Shokouhi, Shervin ;

Lotfollahi, Legha ;

Mardani, Masoud ;

Haghighi-Morad, Maryam ;

Nassiri, Amir Ahmad ;

Rangraz, Davoud ;

Falahaty, Hassan ;

Syami, Hosein ;

Irannejad, Yaghoob ;

Fallah, Maryam ;

Zangi, Masoud ;

Shafigh, Navid .

BLOOD PURIFICATION, 2023, 52 (01) :8-16

[18] Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: Case series from EUPHAS2 registry [J].

De Rosa, Silvia ;

Cutuli, Salvatore Lucio ;

Ferrer, Ricard ;

Antonelli, Massimo ;

Ronco, Claudio .

ARTIFICIAL ORGANS, 2021, 45 (06) :E187-E194

[19] High-Dose Convalescent Plasma for Treatment of Severe COVID-19 [J].

De Santis, Gil C. ;

Oliveira, Luciana Correa ;

Garibaldi, Pedro M. M. ;

Almado, Carlos E. L. ;

Croda, Julio ;

Arcanjo, Ghislaine G. A. ;

Oliveira, Erika A. F. ;

Tonacio, Adriana C. ;

Langhi Jr, Dante M. ;

Bordin, Jose O. ;

Gilio, Renato N. ;

Palma, Leonardo C. ;

Santos, Elaine, V ;

Haddad, Simone K. ;

Prado Jr, Benedito P. A. ;

Pontelli, Marjorie Cornejo ;

Gomes, Rogerio ;

Miranda, Carlos H. ;

Martins, Maria Auxiliadora ;

Covas, Dimas T. ;

Arruda, Eurico ;

Fonseca, Benedito A. L. ;

Calado, Rodrigo T. .

EMERGING INFECTIOUS DISEASES, 2022, 28 (03) :548-555

[20] Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial [J].

Declercq, Jozefien ;

Van Damme, Karel F. A. ;

De Leeuw, Elisabeth ;

Maes, Bastiaan ;

Bosteels, Cedric ;

Tavernier, Simon J. ;

De Buyser, Stefanie ;

Colman, Roos ;

Hites, Maya ;

Verschelden, Gil ;

Fivez, Tom ;

Moerman, Filip ;

Demedts, Ingel K. ;

Dauby, Nicolas ;

De Schryver, Nicolas ;

Govaerts, Elke ;

Vandecasteele, Stefaan J. ;

Van Laethem, Johan ;

Anguille, Sebastien ;

van Der Hilst, Jeroen ;

Misset, Benoit ;

Slabbynck, Hans ;

Wittebole, Xavier ;

Lienart, Fabienne ;

Legrand, Catherine ;

Buyse, Marc ;

Stevens, Dieter ;

Bauters, Fre ;

Seys, Leen J. M. ;

Aegerter, Helena ;

Smole, Ursula ;

Bosteels, Victor ;

Hoste, Levi ;

Naesens, Leslie ;

Haerynck, Filomeen ;

Vandekerckhove, Linos ;

Depuydt, Pieter ;

van Braeckel, Eva ;

Rottey, Sylvie ;

Peene, Isabelle ;

Van Der Straeten, Catherine ;

Hulstaert, Frank ;

Lambrecht, Bart N. .

LANCET RESPIRATORY MEDICINE, 2021, 9 (12) :1427-1438

← 1 2 3 4 5 6 7 8 9 10 →